Permeability barrier disorder in Niemann-Pick disease: Sphingomyelin-ceramide processing required for normal barrier homeostasis

Citation
M. Schmuth et al., Permeability barrier disorder in Niemann-Pick disease: Sphingomyelin-ceramide processing required for normal barrier homeostasis, J INVES DER, 115(3), 2000, pp. 459-466
Citations number
75
Categorie Soggetti
Dermatology,"da verificare
Journal title
JOURNAL OF INVESTIGATIVE DERMATOLOGY
ISSN journal
0022202X → ACNP
Volume
115
Issue
3
Year of publication
2000
Pages
459 - 466
Database
ISI
SICI code
0022-202X(200009)115:3<459:PBDIND>2.0.ZU;2-A
Abstract
Prior studies have established the requirement for enzymatic hydrolysis of glucosylceramides to ceramide for epidermal barrier homeostasis. In this st udy, we asked whether sphingomyelin-derived ceramide, resulting from acid-s phingomyelinase activity, is also required for normal barrier function. We showed first, that a subset of Niemann-Pick patients with severe acid-sphin gomyelinase deficiency (i.e., <2% residual activity) demonstrate abnormal p ermeability barrier homeostasis, i.e., delayed recovery kinetics following acute barrier disruption by cellophane tape-stripping. To obtain further me chanistic insights into the potential requirement for sphingomyelin-to-cera mide processing for the barrier, we next studied the role of acid-sphingomy elinase in hairless mouse skin. Murine epidermis contains abundant acid-sph ingomyelinase activity (optimal pH 5.1-5.6). Two hours following acute barr ier disruption by tape-stripping, acid-sphingomyelinase activity increases 1.44-fold (p<0.008 versus vehicle-treated controls), an increase that is bl ocked by a single topical application of the acid-sphingomyelinase inhibito r, palmitoyldihydrosphingosine. Furthermore, both palmitoyldihydrosphingosi ne and desipramine, a chemically and mechanically unrelated acid-sphingomye linase inhibitor, significantly delay barrier recovery both 2 and 4 h after acute barrier abrogation. Inhibitor application also causes both an increa se in sphingomyelin content, and a reduction of normal extracellular lamell ar membrane structures, in the stratum corneum. Both of the inhibitor-induc ed delays in barrier recovery can be overridden by co-applications of topic al ceramide, demonstrating that an alteration of the ceramide-sphingomyelin ratio, rather than sphingomyelin accumulation, is likely responsible for t he barrier abnormalities that occur with acid-sphingomyelinase deficiency. These studies demonstrate an important role for enzymatic processing of sph ingomyelin-to-ceramide by acid-sphingomyelinase as a mechanism for generati ng a portion of the stratum corneum ceramides for permeability barrier home ostasis in mammalian skin.